VEA
TWST icon

Virtus ETF Advisers’s Twist Bioscience TWST Stock Holding History

Virtus ETF Advisers’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$486K Buy
+4,726
New +$308K 0.19% 141
2025
Q3 		– Sell
-3,004
Closed -$111K – 522
2025
Q2 		$111K Sell
3,004
-18,287
-86% -$632K 0.07% 281
2025
Q1 		$836K Buy
+21,291
New +$959K 0.54% 41

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Virtus ETF Advisers's TWST Position: Q2 2026 in Review

Virtus ETF Advisers opened a new position in Twist Bioscience (TWST) in Q2 2026: 4,726 shares worth $486K. The stake represents 0.19% of the portfolio and ranks #141 among its holdings. This is a return to the name: Virtus ETF Advisers previously reported a position in TWST as recently as Q2 2025.

Virtus ETF Advisers first reported a position in TWST in Q1 2025 and has held it in 3 quarters since. The position peaked at $836K in Q1 2025. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Virtus ETF Advisers held 4,726 shares of Twist Bioscience worth $486K as of Q2 2026.
  • Twist Bioscience was a new Virtus ETF Advisers position in Q2 2026.
  • Twist Bioscience made up 0.19% of Virtus ETF Advisers's portfolio in Q2 2026, its #141 holding.
  • Virtus ETF Advisers first reported a position in Twist Bioscience in Q1 2025 and has held it in 3 quarters since.
  • Virtus ETF Advisers's Twist Bioscience position peaked at $836K in Q1 2025.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.